Cardiol Therapeutics Stock Forecast - Value At Risk
| CRDL Stock | USD 1.58 0.05 3.27% |
Cardiol Stock Forecast is based on your current time horizon. Although Cardiol Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cardiol Therapeutics' systematic risk associated with finding meaningful patterns of Cardiol Therapeutics fundamentals over time.
Cardiol |
| Check Cardiol Therapeutics Volatility | Backtest Cardiol Therapeutics | Information Ratio |
Cardiol Therapeutics Trading Date Momentum
| On November 29 2024 Cardiol Therapeutics Class was traded for 1.58 at the closing time. The top price for the day was 1.60 and the lowest listed price was 1.49 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 3.16% . |
| Compare Cardiol Therapeutics to competition |
Other Forecasting Options for Cardiol Therapeutics
For every potential investor in Cardiol, whether a beginner or expert, Cardiol Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardiol Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardiol. Basic forecasting techniques help filter out the noise by identifying Cardiol Therapeutics' price trends.Cardiol Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiol Therapeutics stock to make a market-neutral strategy. Peer analysis of Cardiol Therapeutics could also be used in its relative valuation, which is a method of valuing Cardiol Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cardiol Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cardiol Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cardiol Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cardiol Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By undertsting and applying Cardiol Therapeutics stock market strength indicators, traders can identify Cardiol Therapeutics Class entry and exit signals to maximize returns.
Cardiol Therapeutics Risk Indicators
The analysis of Cardiol Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardiol Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardiol stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.91 | |||
| Standard Deviation | 3.75 | |||
| Variance | 14.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. If investors know Cardiol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiol Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Return On Assets (0.54) | Return On Equity (1.08) |
The market value of Cardiol Therapeutics is measured differently than its book value, which is the value of Cardiol that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiol Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cardiol Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiol Therapeutics' market value can be influenced by many factors that don't directly affect Cardiol Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.